正在加载公司
Just reported
From Mckesson's results release of 2026年11月4日; its quarterly report has since been filed.
Actual
US$110.96B
+7.6% y/y
+5.3% q/q
Guided
—
No guide given
Actual
US$10.44
+17% y/y
+103% q/q
Guided
—
No guide given
EPS, adjusted: US$11.68
Actual
US$1.6B
+14% y/y
+22% q/q
Guided
—
No guide given
Full year 2027
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Mckesson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
All 11 graded companies in its industryRose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
GEHCGE Healthcare Technologies Inc.2026年10月28日CAGraded C, now A
BIIBBiogen Inc.2026年10月28日BAGraded B, now A各项收入占比是对FY2026 ended 2026-03-31的估算，并非来自已提交报告的数字。
Prescription-drug distribution
Wholesale supply and delivery of branded, generic, specialty, biosimilar, and over-the-counter medicines to pharmacies and health providers.
Pharmacy business services
Financial, operational, clinical, consulting, and technology services for retail, hospital, and other pharmacies.
Oncology and multispecialty provider services
Specialty-drug distribution, infusion services, direct-to-patient pharmacy services, and support for community oncology and other specialty-care practices.
Prescription access and affordability services
Services that help check insurance coverage, obtain prior authorization, compare prescription prices, support dispensing, and enroll patients in assistance programs.
Biopharmaceutical logistics and distribution
Storage, transport, and distribution services for biopharmaceutical manufacturers, including products requiring temperature-controlled handling.
Medical, surgical, and laboratory supplies
Distribution of branded and McKesson's own medical, surgical, and laboratory products to care providers outside acute-care hospitals.
McKesson buys medicines from manufacturers and sells and delivers them to pharmacies, hospitals, and other care providers. It also distributes specialty medicines and supports community oncology practices with services, research, and technology. Its prescription services help connect patients, pharmacies, providers, health plans, and drug manufacturers to handle coverage checks, prior authorization, and affordability programs. It also supplies medical, surgical, and laboratory products to care providers outside hospitals.
基于 Mckesson Corporation 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。
McKesson distributes prescription drugs to pharmacies, hospitals, and clinics, with a smaller business selling medical supplies to care providers.
Grade A
价格下方的色带显示每个日期的评级，仅依据当时已公开的文件计算。
显示 Mckesson Corporation 评级历史 41 个季度中的 2 个。 其余 39 个可回溯到 2016年10月。
